Red Cell Distribution Width Is Associated with Presence, Stage, and Grade in Patients with Renal Cell Carcinoma

Red cell distribution width is a prognostic factor in severe sepsis and septic shock

(2013) You Hwan Jo et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case-control study in China

(2013) Gui-Ming Zhang et al.   BJU INTERNATIONAL

Red Blood Cell Distribution and Survival in Patients with Chronic Obstructive Pulmonary Disease

(2013) Ekrem Cengiz Seyhan et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Evaluation of Red Blood Cell Distribution Width in Patients with Cardiac Syndrome X

(2013) Ping Qing et al.   DISEASE MARKERS

Increased Red Blood Cell Distribution Width Associates with Cancer Stage and Prognosis in Patients with Lung Cancer

(2013) Yasuko Koma et al.   PLoS One

Clinical Usefulness of Measuring Red Blood Cell Distribution Width in Patients with Hepatitis B

(2012) YuFeng Lou et al.   PLoS One

Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction

(2012) Jinkwon Kim et al.   THROMBOSIS AND HAEMOSTASIS

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Risk factor for clear cell renal cell carcinoma in Chinese population: A case–control study

(2011) Guoping Wang et al.   Cancer Epidemiology

Immunologic mechanisms in RCC and allogeneic renal transplant rejection

(2010) Jens Bedke et al.   Nature Reviews Urology

Red cell distribution width in heart failure: Prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state

(2009) Zsolt Förhécz et al.   AMERICAN HEART JOURNAL

Usefulness of Red Cell Distribution Width as a Prognostic Marker in Pulmonary Hypertension††Conflicts of interest: Dr. Gomberg-Maitland has received research grant support from Actelion Pharmaceuticals Ltd., Allschwil, Switzerland; CoTherix, Inc., South San Francisco, California; Encysive Pharmaceuticals Inc., Houston, Texas; Gilead Sciences Inc., Foster City, California; Eli Lilly/ICOS, Indianapolis, Indiana; Pfizer Inc., New York, New York; and United Therapeutics, Silver Spring, Maryland. Dr. Gomberg-Maitland has served as a consultant and/or on advisory boards for Encysive Pharmaceuticals Inc., Gilead Sciences Inc., Pfizer Inc., and United Therapeutics. Dr. Shah has received research grant support from Actelion Pharmaceuticals Ltd. (Entelligence Young Investigator Award) and is also the recipient of a Scientist Development Grant from the American Heart Association, Dallas, Texas.

(2009) Chetan V. Hampole et al.   AMERICAN JOURNAL OF CARDIOLOGY

Relation Between Red Cell Distribution Width and Clinical Outcomes After Acute Myocardial Infarction

(2009) Saleem Dabbah et al.   AMERICAN JOURNAL OF CARDIOLOGY

Red Blood Cell Distribution Width and Risk of Cardiovascular Events and Mortality in a Community Cohort in Taiwan

(2009) P.-C. Chen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Red Blood Cell Distribution Width and Mortality Risk in a Community-Based Prospective Cohort

(2009) Todd S. Perlstein et al.   ARCHIVES OF INTERNAL MEDICINE

Red Blood Cell Distribution Width and the Risk of Death in Middle-aged and Older Adults

(2009) Kushang V. Patel et al.   ARCHIVES OF INTERNAL MEDICINE

Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients

(2009) Domingo A. Pascual-Figal et al.   EUROPEAN JOURNAL OF HEART FAILURE

Red Cell Distribution Width for Assessment of Activity of Inflammatory Bowel Disease

(2008) Basak Cakal et al.   DIGESTIVE DISEASES AND SCIENCES

Elevated red blood cell distribution width predicts mortality in persons with known stroke

(2008) Chizobam Ani et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE